Phillip Pang, Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 11,909 shares at $44.10 ($517K) on 2021-12-01, disclosed to the SEC on 2021-12-03.
Open-market sale of $517k VIR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.82 | 950 | $40K | 7.7% |
| 2 | $43.46 | 4,409 | $192K | 37.0% |
| 3 | $43.46 | 4,409 | $192K | 37.0% |
| 4 | $44.10 | 2,050 | $90K | 17.5% |
| 5 | $44.97 | 91 | $4K | 0.8% |
| Total | $43.45 avg | 11,909 |
| $517K |
| 100% |
| Filing → |
| VIR | SELL | 2023-06-08 | $130K | — | Filing → |
| VIR | SELL | 2023-02-28 | $238K | — | Filing → |
| VIR | SELL | 2023-02-24 | $149K | — | Filing → |